Universe Pharmaceuticals (UPC) Invested Capital (2020 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Invested Capital for 6 consecutive years, with $58.2 billion as the latest value for Q3 2025.
- Quarterly Invested Capital rose 13.39% to $58.2 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $58.2 billion through Sep 2025, up 13.39% year-over-year, with the annual reading at $58.2 billion for FY2025, 13.39% up from the prior year.
- Invested Capital hit $58.2 billion in Q3 2025 for Universe Pharmaceuticals, up from $51.4 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $58.2 billion in Q3 2025 to a low of $47.0 million in Q3 2021.
- Historically, Invested Capital has averaged $34.6 billion across 5 years, with a median of $35.3 billion in 2022.
- Biggest five-year swings in Invested Capital: skyrocketed 75059.29% in 2022 and later dropped 20.82% in 2023.
- Year by year, Invested Capital stood at $47.0 million in 2021, then surged by 75059.29% to $35.3 billion in 2022, then fell by 20.82% to $28.0 billion in 2023, then skyrocketed by 83.59% to $51.4 billion in 2024, then rose by 13.39% to $58.2 billion in 2025.
- Business Quant data shows Invested Capital for UPC at $58.2 billion in Q3 2025, $51.4 billion in Q3 2024, and $28.0 billion in Q3 2023.